References
- Avouac B., Teule M.1988. Ketoprofen: the European experience. J Clin Pharmacol, 28(s1):S2-7
- Novelli R., Aramini A., Boccella S., Bagnasco M., Cattani F., Ferrari M.P., Goisis G., Minnella E.M., Allegretti M., Pace V.2022. Ketoprofen lysine salt has a better gastrointestinal and renal tolerability than ketoprofen acid: A comparative tolerability study in the Beagle dog. Biomed Pharmacother,153:113336.
- Brandolini L., d’Angelo M., Antonosante A., Villa S., Cristiano L., Castelli V., Benedetti E., Catanesi M., Aramini A., Luini A., Parashuraman S., Mayo E., Giordano A., Cimini A., Allegretti M.2018. Differential protein modulation by ketoprofen and ibuprofen underlines different cellular response by gastric epithelium. J Cell Physiol,233(3):2304-2312.
- Cimini A., Brandolini L., Gentile R., Cristiano L., Menghini P., Fidoamore A., Antonosante A., Benedetti E., Giordano A., Allegretti M. 2015.Gastroprotective effects of L-lysine salification of ketoprofen in ethanol-injured gastric mucosa. J Cell Physiol,230(4):813-20.
- Aramini A., Bianchini G., Lillini S., Bordignon S., Tomassetti M., Novelli R., Mattioli S., Lvova L., Paolesse R., Chierotti M.R., Allegretti M.2021. Unexpected Salt/Cocrystal Polymorphism of the Ketoprofen-Lysine System: Discovery of a New Ketoprofen-l-Lysine Salt Polymorph with Different Physicochemical and Pharmacokinetic Properties. Pharmaceuticals (Basel),14(6):555.
- Scheller J., Chalaris A., Schmidt-Arras D., Rose-John S.2011. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta,1813(5):878-88.
- Kaplanski G., Marin V., Montero-Julian F., Mantovani A., Farnarier C.2002. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol,24(1):25-9.
- Romano M., Sironi M., Toniatti C., Polentarutti N., Fruscella P., Ghezzi P., Faggioni R., Luini W., van Hinsbergh V., Sozzani S., Bussolino F., Poli V., Ciliberto G., Mantovani A. 1997.Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity,6(3):315-25.
- Chen Q., Wang W.C., Bruce R., Li H., Schleider D.M., Mulbury M.J., Bain M.D., Wallace P.K., Baumann H., Evans S.S.2004. Central role of IL-6 receptor signal-transducing chain gp130 in activation of L-selectin adhesion by fever-range thermal stress. Immunity,20(1):59-70.
- Matthews V.B., Allen T.L., Risis S., Chan M.H., Henstridge D.C., Watson N., Zaffino L.A., Babb J.R., Boon J., Meikle P.J., Jowett J.B., Watt M.J., Jansson J.O., Bruce C.R., Febbraio M.A. 2010.Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia,53(11):2431-41.
- Wunderlich F.T., Ströhle P., Könner A.C., Gruber S., Tovar S., Brönneke H.S., Juntti-Berggren L., Li L.S., van Rooijen N., Libert C., Berggren P.O., Brüning J.C.2010. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metab,12(3):237-49.
- Nishimoto N., Kanakura Y., Aozasa K., Johkoh T., Nakamura M., Nakano S., Nakano N., Ikeda Y., Sasaki T., Nishioka K., Hara M., Taguchi H., Kimura Y., Kato Y., Asaoku H., Kumagai S., Kodama F., Nakahara H., Hagihara K., Yoshizaki K., Kishimoto T.2005. Humanized anti-interleukin- 6 receptor antibody treatment of multicentric Castleman disease. Blood, 106(8):2627-32.
- Peters M., Schirmacher P., Goldschmitt J., Odenthal M., Peschel C., Fattori E., Ciliberto G., Dienes H.P., Meyer zum Büschenfelde K.H., Rose- John S. 1997.Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice. J Exp Med,185(4):755-66.
- Febbraio M.A., Rose-John S., Pedersen B.K.2010. Is interleukin-6 receptor blockade the Holy Grail for inflammatory diseases? Clin Pharmacol Ther,87(4):396-8.
- Obreja O., Schmelz M., Poole S., Kress M.2002. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain,96(1-2):57-62.
- Murphy P.G., Ramer M.S., Borthwick L., Gauldie J., Richardson P.M., Bisby M.A. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci,11(7):2243-53.
- Sheppard M., Laskou F., Stapleton P.P., Hadavi S., Dasgupta B.2017. Tocilizumab (Actemra). Hum Vaccin Immunother,13(9):1972-1988.
- Mollazadeh H., Cicero A.F.G., Blesso C.N., Pirro M., Majeed M., Sahebkar A.2019. Immune modulation by curcumin: The role of interleukin-10. Crit Rev Food Sci Nutr, 59(1):89-101.
- Saraiva M., Vieira P., O’Garra A.2020. Biology and therapeutic potential of interleukin-10. J Exp Med,217(1):e20190418.
- Kelley K.W., Dantzer R.2011. Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders. Brain Behav Immun,25 Suppl 1(0 1):S13-20.
- Aalykke C., Lauritsen K.2001. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol,15(5):705-22.
- Smaga A., Bogusławski S., Wróbel K., Wojtyniak B.2022. Rozpowszechnienie behawioralnych czynników ryzyka zdrowotnego i jego zmiany w okresie pandemii COVID-19.In: Wojtyniak B., Goryński P. Eds. Sytuacja zdrowotna ludności Polski i jej uwarunkowania 2022.Narodowy Instytut Zdrowia Publicznego PZH-– Państwowy Instytut Badawczy, Warszawa 2022 (In Polish).
- Barbería-Latasa M., Gea A., Martínez-González M.A.2022. Alcohol, Drinking Pattern, and Chronic Disease. Nutrients,14(9):1954.
- Aziz F., Chakraborty A., Liu K., Zhang T., Li X., Du R., Monts J., Xu G., Li Y., Bai R., Dong Z.2022. Gastric tumorigenesis induced by combining Helicobacter pylori infection and chronic alcohol through IL-10 inhibition. Carcinogenesis,43(2):126-139.
- Aramini A., Bianchini G., Lillini S., Tomassetti M., Pacchiarotti N., Canestrari D., Cocchiaro P., Novelli R., Dragani M.C., Palmerio F., Mattioli S., Bordignon S., d’Angelo M., Castelli V., d’Egidio F., Maione S., Luongo L., Boccella S., Cimini A., Brandolini L., Chierotti M.R., Allegretti M.2023. Ketoprofen, lysine and gabapentin co-crystal magnifies synergistic efficacy and tolerability of the constituent drugs: Pre-clinical evidences towards an innovative therapeutic approach for neuroinflammatory pain. Biomed Pharmacother,163:114845.
- Skurk T., Alberti-Huber C., Herder C., Hauner H.2007. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab,92(3):1023-33.
- Hotamisligil G.S. 2006.Inflammation and metabolic disorders. Nature,444(7121):860-7.
- Anesten F., Dalmau Gasull A., Richard J.E., Farkas I., Mishra D., Taing L., Zhang F., Poutanen M., Palsdottir V., Liposits Z., Skibicka K.P., Jansson J.O.2019. Interleukin-6 in the central amygdala is bioactive and co-localised with glucagon-like peptide-1 receptor. J Neuroendocrinol,31(6):e12722.
- Bornath D.P.D., McKie G.L., McCarthy S.F., Vanderheyden L.W., Howe G.J., Medeiros P.J., Hazell T.J.2023. Interleukin-6 is not involved in appetite regulation following moderate-intensity exercise in males with normal weight and obesity. Obesity (Silver Spring),31(9):2315-2324.
- Roleder N., Aringer M., Boentert M.2012. Role of interleukin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci,1261:88-96.
- Martinez F., Abril E.R., Earnest D.L., Watson R.R. 1992.Ethanol and cytokine secretion. Alcohol. 9(6):455-8.
- Martins T.L., Kahvegian M.A., Noel-Morgan J., Leon-Román M.A., Otsuki D.A., Fantoni D.T.2010. Comparison of the effects of tramadol, codeine, and ketoprofen alone or in combination on postoperative pain and on concentrations of blood glucose, serum cortisol, and serum interleukin-6 in dogs undergoing maxillectomy or mandibulectomy. Am J Vet Res,71(9):1019-26.
- Caton S.J., Nolan L.J., Hetherington M.M.2015. Alcohol, Appetite and Loss of Restraint. Curr Obes Rep,4(1):99-105.
- Kuczyńska J., Nieradko-Iwanicka B.2021. The effect of ketoprofen lysine salt on mucosa of rat stomach after ethyl alcohol intoxication. Biomed Pharmacother,141:111938.
- Arab H.H., Saad M.A., El-Sahar A.E., Al-Shorbagy M.Y.2020. Mechanistic perspective of morin protection against ketoprofen-induced gastric mucosal injury: Targeting HMGB1/RAGE/NF-κB, DJ-1/Nrf2/HO-1 and PI3K/mTOR pathways. Arch Biochem Biophys,693:108552.
- Schunck R.V., Torres I.L., Laste G., de Souza A., Macedo I.C., Valle M.T., Salomón J.L., Moreira S., Kuo J., Arbo M.D., Dallegrave E., Leal M.B.2015. Protracted alcohol abstinence induces analgesia in rats: Possible relationships with BDNF and interleukin-10. Pharmacol Biochem Behav,135:64-9.
- Murakami S., Imamura M., Uchida T., Suehiro Y., Namba M., Fujii Y., Uchikawa S., Teraoka Y., Fujino H., Ono A., Nakahara T., Murakami E., Okamoto W., Yamauchi M., Kawaoka T., Miki D., Hayes N.C., Tsuge M., Aikata H., Ohira M., Ohdan H., Oka S.2023. Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure. Hepatol Int,17(5):1225-1232.
- Tablov B., Stavreva S., Tablov V., Popov I., Konova E.2007. [Immunological aspects of postoperative analgesia after abdominal hysterectomy]. Akush Ginekol (Sofiia)46(1):18-24.
- Kuczyńska J., Pawlak A., Nieradko-Iwanicka B.2022. The comparison of dexketoprofen and other painkilling medications (review from 2018 to 2021). Biomed Pharmacother,. 149:112819.
- Piirainen A., Kokki M., Hautajärvi H., Lehtonen M., Miettinen H., Pulkki K., Ranta V.P., Kokki H.2016. The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty. Clin Drug Investig,36(7):545-55.
- Al-Hakeim H.K., Twayej A.J., Al-Dujaili A.H., Maes M.2020. Plasma indoleamine-2,3-dioxygenase (ido) is increased in drug-naïve major depressed patients and treatment with sertraline and ketoprofen normalizes ido in association with pro-inflammatory and immune-regulatory cytokines. CNS Neurol. Disord. - Drug Targets,19(1):44–54.
- Kuczyńska J., Nieradko-Iwanicka B. 2023.Comparison of the effects of ketoprofen and ketoprofen lysine salt on the Wistar rats’ nervous system, kidneys and liver after ethyl alcohol intoxication. Biomed Pharmacother,161:114456.